Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio

IMPORTANCE: In a comparative clinical study with progression-free survival (PFS) or overall survival (OS) as the end point, the hazard ratio (HR) is routinely used to design the study and to estimate the treatment effect at the end of the study. The clinical interpretation of the HR may not be strai...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Oncol
Autors principals: Pak, Kyongsun, Uno, Hajime, Kim, Dae Hyun, Tian, Lu, Kane, Robert C., Takeuchi, Masahiro, Fu, Haoda, Claggett, Brian, Wei, Lee-Jen
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2017
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5824272/
https://ncbi.nlm.nih.gov/pubmed/28975263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2017.2797
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars